New Project Steps2Scale NRW Successfully Launched
With the kick-off meeting, the Steps2Scale NRW project, funded by the German Federal Ministry for Economic Affairs and Energy (BMWE), has officially started. Together with our partners, we are excited to lay the foundations over the coming months for a potential Scale-up Hub for industrial biotechnology in North Rhine-Westphalia.
The project aims to support companies in overcoming the critical stage between technology development and market implementation. In particular, the transition from pilot to demonstration scale (TRL 6-8) presents significant technical and economic challenges for many biotechnological innovations. The planned Scale-up Hub NRW is intended to address this challenge by providing flexible infrastructure and support services for the scale-up of biotechnological processes. The hub is planned to be located at the Bayer AG site in Bergkamen, which offers extensive fermentation capacities, established industrial infrastructure, and many years of experience in combining biotechnological and chemical processes.
Within the project, two key areas are being addressed to support the development of the Scale-up Hub NRW: 1) The design of the technical infrastructure, tailored to the anticipated needs of future users, and 2) the development of an operating and business model for the hub.
A key focus of the project’s first phase is therefore the assessment of actual industry demand. As part of the first work package, a comprehensive demand assessment has been developed. The survey aims to identify both current and future requirements regarding process scale-up, production capacities, and associated technical needs.
Your participation is therefore essential!
We kindly invite you to participate in the survey and complete the questionnaire linked here as thoroughly and comprehensively as possible.Only a detailed understanding of current market requirements will ensure that the future Scale-up Hub NRW is optimally aligned with the needs of its future users.
Participate Now: https://www.surveymonkey.com/r/R6GHYHC
As an added benefit, all participants who provide their contact details will receive an exclusive executive summary of the results, offering valuable insights into current trends, requirements, and developments within the biotechnology scale-up landscape.
Participation is voluntary and responses may be submitted either anonymously or with contact information. Any personal data provided will be treated confidentially and in accordance with the requirements of the GDPR. Data will be used solely for the purposes of this survey and will not be shared with or disclosed to any third parties.
